Inventor · disambiguated record
Mark Connors
Also filed as: CONNORS MARK
19 granted patents·7 pending applications·190 citations·filing 1994–2024
94Inventor score
Files withUS HEALTH19MASCOLA JOHN R2ALTOR BIOSCIENCE LLC1SANOFI SA1THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN1
Top patents by PatentIndex Score
26 records- 0194US10035844B2Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope proteinUS HEALTH·Filed 2017·Granted Jul 31, 2018·6 cites·32 claims
- 0294US5922326AAttenuated respiratory syncytial virus vaccine compositionsUS HEALTH·Filed 1994·Granted Jul 13, 1999·109 cites·26 claims
- 0393US8637036B2Neutralizing antibodies to HIV-1 and their useMASCOLA JOHN R·Filed 2012·Granted Jan 28, 2014·22 cites·23 claims
- 0491US9695230B2Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope proteinUS HEALTH·Filed 2012·Granted Jul 4, 2017·9 cites·41 claims
- 0590US12202886B2Neutralizing antibodies to GP120 and their useUS HEALTH·Filed 2022·Granted Jan 21, 2025·1 cites·11 claims
- 0690US10562960B2Neutralizing antibodies to gp120 and their useUS HEALTH·Filed 2016·Granted Feb 18, 2020·5 cites·41 claims
- 0786US2025215068A1Neutralizing antibodies to gp120 and their useUS HEALTH·Filed 2024·Application pending·0 cites
- 0885US9738703B2Neutralizing antibodies to HIV-1 and their useUS HEALTH·Filed 2015·Granted Aug 22, 2017·2 cites·21 claims
- 0984US9475862B2Neutralizing GP41 antibodies and their useUS HEALTH·Filed 2012·Granted Oct 25, 2016·6 cites·22 claims
- 1084US9175070B2Neutralizing antibodies to HIV-1 and their useMASCOLA JOHN R·Filed 2010·Granted Nov 3, 2015·4 cites·7 claims
- 1180US10035845B2Neutralizing antibodies to HIV-1 and their useUS HEALTH·Filed 2017·Granted Jul 31, 2018·2 cites·21 claims
- 1272US2021324053A1Neutralizing antibodies to gp120 and their useTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN·Filed 2021·Application pending·0 cites
- 1366US2020231658A1Neutralizing antibodies to gp120 and their useTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2020·Application pending·0 cites
- 1465US10815295B2Broadly neutralizing HIV-1 antibodies that bind to the CD4-binding site of the envelope proteinUS HEALTH·Filed 2018·Granted Oct 27, 2020·0 cites·6 claims
- 1565US9783595B2Neutralizing GP41 antibodies and their useUS HEALTH·Filed 2016·Granted Oct 10, 2017·0 cites·28 claims
- 1662US5882651AAttenuated respiratory syncytial virus vaccine compositionsUS HEALTH·Filed 1995·Granted Mar 16, 1999·19 cites·16 claims
- 1761US12043660B210E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 and their useUS HEALTH·Filed 2021·Granted Jul 23, 2024·0 cites·19 claims
- 1861US10047148B2Neutralizing GP41 antibodies and their useUS HEALTH·Filed 2017·Granted Aug 14, 2018·0 cites·25 claims
- 1961US2024293532A1Replication-competent adenovirus type 4 sars-cov-2 vaccines and their useUS HEALTH·Filed 2022·Application pending·0 cites
- 2058US10047147B2Neutralizing GP41 antibodies and their useUS HEALTH·Filed 2014·Granted Aug 14, 2018·0 cites·12 claims
- 2157US2019054182A1Trispecific and/or trivalent binding proteins for prevention or treatment of hiv infectionSANOFI SA·Filed 2016·Application pending·0 cites
- 2255US11236152B2Neutralizing antibodies to HIV-1 GP41 and their useUS HEALTH·Filed 2016·Granted Feb 1, 2022·0 cites·22 claims
- 2353US2011052631A1Induction of proliferation, effector molecule expression, and cytolytic capacity of hiv-specific cd8+ t cellsUS HEALTH·Filed 2009·Application pending·0 cites
- 2446US12325734B2Human immunodeficiency virus-specific T cell receptorsALTOR BIOSCIENCE LLC·Filed 2020·Granted Jun 10, 2025·0 cites·11 claims
- 2542US6284254B1Immunogenic compositions comprising cold-adapted attenuated respiratory syncytial virus mutantsUS HEALTH·Filed 1995·Granted Sep 4, 2001·5 cites·12 claims
- 2642US2015044137A1Neutralizing antibodies to hiv-1 and their useUS OF AMERICA AS REPRESENTED BY THE SECRETARY DEP OF HEALTH CARE HUMAN SERVICES·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Connors files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →